Clinical Trials

169 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT04301778 2026-03-13

Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma

5 enrolled 13 charts

Cholangiocarcinoma

NCT06381648 2026-03-13

LyMIC

230 enrolled

Lymphatic Metastasis, Cholangiocarcinoma

NCT07224737 2026-03-13

EXOMIC

230 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Liver Neoplasms, Recurrence, Cholangiocarcinoma

NCT07225452 2026-03-13

LUMIC

535 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Liver Neoplasms, Cholangiocarcinoma

NCT04238715 2026-03-02

A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion

63 enrolled

Acrocephalosyndactylia, Cholangiocarcinoma

NCT04526106 2026-02-27

REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

Phase 1/2 Completed

490 enrolled

Cholangiocarcinoma

NCT04233567 2026-02-24

Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations

17 enrolled 12 charts

Neoplasm Metastasis, Cholangiocarcinoma

NCT05993429 2026-01-26

Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma

200 enrolled

Cholangiocarcinoma, Klatskin Tumor

NCT05641896 2026-01-22

18F-FAPI-74 GI

109 enrolled

Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT05348811 2026-01-06

HAIC Combined With Donafenib and Sintilimab for Unresectable ICC

25 enrolled

Cholangiocarcinoma

NCT07319767 2026-01-06

Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors

120 enrolled

BreastGastrointestinal

Biliary Tract Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT07304388 2025-12-30

HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC

96 enrolled